Welcome to MyStrategist, the digital home for MedTech Strategist.

MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


MedTech Innovator Presents

In Spine, Orthomod Bridges the Hardware/Biologic Divide

With a new orthopedic biomaterial that unites the healing properties of biologics with the strength of load-bearing implants, Orthomod can operate in spine, trauma, cancer-related bone void filling, and other applications.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Start-Ups

Solenic Treats Prosthetic Joint Infections Noninvasively

The patient who develops a knee implant infection is likely to face several repeat surgeries within five years, during which the surgeon enters the joint to aggressively debride the implant and administer antibiotics, and, frequently, to remove the implant. Solenic offers a repeatable, noninvasive method of infection control through the application of thermal energy generated by alternating magnetic fields.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Business Strategies

In the Ever-Shifting Diabetes Device Market, Flexibility and Focus Are Key

Medtronic’s plan to exit the diabetes device market via spin-off could have major implications for the competitive landscape. But even though the landscape is shifting, growth indicators remain strong as pump competitors Insulet and Tandem Diabetes Care make inroads into type 2 diabetes, Dexcom and Abbott tap new opportunities for CGMs, and newcomers line up with device innovations of their own.

Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with Market Pathways.

Subscribe   Free Premier Issue   Learn More